On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.

O Caffo; V Zagonel; C Baldessari; A Berruti; R Bortolus; S Buti; G L Ceresoli; M Donini; P Ermacora; G Fornarini; L Fratino; C Masini; F Massari; A Mosca; C Mucciarini; G Procopio; M Tucci; E Verri; P Zucali; C Buttigliero

doi:10.1016/j.annonc.2020.06.005

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.

O Caffo, V Zagonel, C Baldessari, A Berruti, R Bortolus, S Buti, G L Ceresoli, M Donini, P Ermacora, G Fornarini, L Fratino, C Masini, F Massari, A Mosca, C Mucciarini, G Procopio, M Tucci, E Verri, P Zucali, C Buttigliero

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1415-1416
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	31
DOIs	https://doi.org/10.1016/j.annonc.2020.06.005
Publication status	Published - Oct 1 2020

Access to Document

10.1016/j.annonc.2020.06.005

Cite this

Caffo, O., Zagonel, V., Baldessari, C., Berruti, A., Bortolus, R., Buti, S., Ceresoli, G. L., Donini, M., Ermacora, P., Fornarini, G., Fratino, L., Masini, C., Massari, F., Mosca, A., Mucciarini, C., Procopio, G., Tucci, M., Verri, E., Zucali, P., & Buttigliero, C. (2020). On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. Annals of oncology : official journal of the European Society for Medical Oncology, 31, 1415-1416. https://doi.org/10.1016/j.annonc.2020.06.005

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. / Caffo, O; Zagonel, V; Baldessari, C; Berruti, A; Bortolus, R; Buti, S; Ceresoli, G L; Donini, M; Ermacora, P; Fornarini, G ; Fratino, L ; Masini, C ; Massari, F; Mosca, A; Mucciarini, C; Procopio, G; Tucci, M; Verri, E ; Zucali, P; Buttigliero, C.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 31, 01.10.2020, p. 1415-1416.

Research output: Contribution to journal › Article › peer-review

Caffo, O, Zagonel, V, Baldessari, C, Berruti, A, Bortolus, R, Buti, S, Ceresoli, GL, Donini, M, Ermacora, P, Fornarini, G , Fratino, L , Masini, C , Massari, F, Mosca, A, Mucciarini, C, Procopio, G, Tucci, M, Verri, E , Zucali, P & Buttigliero, C 2020, 'On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31, pp. 1415-1416. https://doi.org/10.1016/j.annonc.2020.06.005

Caffo, O ; Zagonel, V ; Baldessari, C ; Berruti, A ; Bortolus, R ; Buti, S ; Ceresoli, G L ; Donini, M ; Ermacora, P ; Fornarini, G ; Fratino, L ; Masini, C ; Massari, F ; Mosca, A ; Mucciarini, C ; Procopio, G ; Tucci, M ; Verri, E ; Zucali, P ; Buttigliero, C. / On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2020 ; Vol. 31. pp. 1415-1416.

@article{8eb58c2b6067480bbf30629edad1e6e6,

title = "On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.",

keywords = "Androgen Antagonists, Betacoronavirus, COVID-19, Coronavirus Infections, Humans, Male, Pandemics, Pneumonia, Viral, Prostatic Neoplasms, epidemiology, SARS-CoV-2, Severe Acute Respiratory Syndrome",

author = "O Caffo and V Zagonel and C Baldessari and A Berruti and R Bortolus and S Buti and Ceresoli, {G L} and M Donini and P Ermacora and G Fornarini and L Fratino and C Masini and F Massari and A Mosca and C Mucciarini and G Procopio and M Tucci and E Verri and P Zucali and C Buttigliero",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/j.annonc.2020.06.005",

language = "Non definita",

volume = "31",

pages = "1415--1416",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.

AU - Caffo, O

AU - Zagonel, V

AU - Baldessari, C

AU - Berruti, A

AU - Bortolus, R

AU - Buti, S

AU - Ceresoli, G L

AU - Donini, M

AU - Ermacora, P

AU - Fornarini, G

AU - Fratino, L

AU - Masini, C

AU - Massari, F

AU - Mosca, A

AU - Mucciarini, C

AU - Procopio, G

AU - Tucci, M

AU - Verri, E

AU - Zucali, P

AU - Buttigliero, C

PY - 2020/10/1

Y1 - 2020/10/1

KW - Androgen Antagonists

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections

KW - Humans

KW - Male

KW - Pandemics

KW - Pneumonia

KW - Viral

KW - Prostatic Neoplasms

KW - epidemiology

KW - SARS-CoV-2

KW - Severe Acute Respiratory Syndrome

U2 - 10.1016/j.annonc.2020.06.005

DO - 10.1016/j.annonc.2020.06.005

M3 - Articolo

VL - 31

SP - 1415

EP - 1416

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -